Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Automated Cell Counter

By Drug Discovery Trends Editor | December 21, 2009

Millipore Corporation, a leading provider of technologies, tools and services for the global life sciences industry, introduced Scepter, the industry’s first handheld, automated cell counter at the American Society of Cell Biology Annual Meeting in San Diego.

Unlike any other cell counter, this handheld device provides researchers with a simple and affordable automated option for counting cells and monitoring the health of their cultures.

Scepter miniaturizes Coulter cell counting technology found in much larger instruments into a portable device the size of an automated pipette. The instrument contains sophisticated electronics for cell sensing, signal processing, and data storage. A graphical display reports the cell count and average cell volume within 20 seconds of inserting the tip into a cell culture sample.

Currently, cells are typically counted manually under a microscope using a hemocytometer. However, loading a hemocytometer is a tedious task and variability in user technique can impact the accuracy and precision of results. Automated cell counters are available, but these bench top instruments are not portable and are considerably more expensive than the Scepter handheld cell counter.

In addition to showing cell counts and average cell volume, the instrument also displays a histogram of cell distribution by volume or diameter. The histogram can be used to provide an instant snap shot of the health of the culture. Results can be stored on the instrument or downloaded to a computer.

The Scepter instrument will be commercially available during the latter half of the first quarter of 2010.

Millipore Corporation


Filed Under: Drug Discovery

 

Related Articles Read More >

China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE